X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1916) 1916
Publication (94) 94
Book Review (27) 27
Book Chapter (9) 9
Dissertation (4) 4
Paper (2) 2
Web Resource (2) 2
Conference Proceeding (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1081) 1081
fixed-dose combination (1060) 1060
index medicus (986) 986
pharmacology & pharmacy (595) 595
male (566) 566
female (521) 521
drug combinations (488) 488
drug therapy, combination (434) 434
middle aged (418) 418
adult (375) 375
hypertension (363) 363
treatment outcome (337) 337
double-blind (317) 317
fixed-dose combinations (283) 283
aged (271) 271
hypertension - drug therapy (264) 264
drug therapy (259) 259
efficacy (225) 225
therapy (225) 225
dosage and administration (203) 203
analysis (185) 185
infectious diseases (179) 179
adherence (178) 178
amlodipine (177) 177
safety (176) 176
pharmacokinetics (175) 175
fixed dose combination (174) 174
care and treatment (170) 170
antihypertensive agents - administration & dosage (163) 163
antihypertensive agents - therapeutic use (159) 159
hiv infections - drug therapy (153) 153
medicine, general & internal (147) 147
research (142) 142
respiratory system (137) 137
blood pressure - drug effects (132) 132
blood-pressure (129) 129
young adult (128) 128
management (126) 126
medicine & public health (126) 126
drugs (125) 125
double-blind method (122) 122
drug dosages (121) 121
internal medicine (121) 121
adolescent (118) 118
patient compliance (117) 117
hydrochlorothiazide (113) 113
health aspects (112) 112
risk factors (112) 112
peripheral vascular disease (111) 111
dose-response relationship, drug (110) 110
hiv (109) 109
prevention (109) 109
review (106) 106
cardiac & cardiovascular systems (103) 103
oncology (103) 103
clinical trials (102) 102
medication adherence (102) 102
blood pressure (100) 100
pharmacology/toxicology (98) 98
tablets (97) 97
pulmonary disease, chronic obstructive - drug therapy (94) 94
cross-over studies (92) 92
patients (92) 92
bioavailability (90) 90
drug administration schedule (90) 90
anti-hiv agents - therapeutic use (89) 89
metformin (89) 89
pharmacology (89) 89
copd (87) 87
open-label (87) 87
tuberculosis (87) 87
antihypertensive agents - adverse effects (86) 86
combination therapy (85) 85
bioequivalence (84) 84
valsartan (84) 84
obstructive pulmonary-disease (81) 81
mortality (80) 80
administration, oral (79) 79
animals (79) 79
immunology (78) 78
retrospective studies (78) 78
aged, 80 and over (76) 76
metaanalysis (76) 76
monotherapy (76) 76
amlodipine - administration & dosage (75) 75
area under curve (75) 75
lamivudine (75) 75
medicine, research & experimental (75) 75
type 2 diabetes (75) 75
chemotherapy (74) 74
child (74) 74
diabetes mellitus, type 2 - drug therapy (73) 73
diabetes (72) 72
medical research (72) 72
tiotropium (72) 72
usage (72) 72
randomized controlled trials as topic (71) 71
medicine (70) 70
chronic obstructive pulmonary disease (69) 69
anti-hiv agents - administration & dosage (68) 68
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1806) 1806
Russian (44) 44
French (16) 16
Spanish (14) 14
Czech (13) 13
German (7) 7
Hungarian (7) 7
Portuguese (6) 6
Polish (4) 4
Italian (3) 3
Japanese (3) 3
Korean (3) 3
Indonesian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes, Obesity and Metabolism, ISSN 1462-8902, 01/2018, Volume 20, Issue 1, pp. 195 - 199
Journal Article
Journal Article
Handbook of Experimental Pharmacology, ISSN 0171-2004, 2016, Volume 237, pp. 117 - 129
Journal Article
Hypertension, ISSN 0194-911X, 02/2014, Volume 63, Issue 2, pp. 259 - 264
Journal Article
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, ISSN 1178-7007, 06/2015, Volume 8, pp. 287 - 294
Journal Article
Journal Article
The Journal of Clinical Hypertension, ISSN 1524-6175, 01/2018, Volume 20, Issue 1, pp. 143 - 149
The single‐pill combination (SPC) comprising nebivolol (5 mg), a vasodilatory β1‐selective antagonist/β3‐agonist, and valsartan (80 mg), a... 
valsartan | nebivolol | antihypertensive agents | hypertension | drug combination | efficacy | MONOTHERAPY | SAFETY | THERAPY | TOLERABILITY | DOUBLE-BLIND | PERIPHERAL VASCULAR DISEASE | FIXED-DOSE COMBINATION | BETA-BLOCKERS | Hypertension | Corticosteroids | Drug therapy, Combination | Aldosterone | Angiotensin | Drug Therapy | Original Paper
Journal Article
Therapeutics and Clinical Risk Management, ISSN 1176-6336, 10/2016, Volume 12, pp. 1497 - 1506
Journal Article